Authors' Reply

. 2022 Apr 29;17(2):309-310.

doi: 10.18502/jovr.v17i2.10825. eCollection 2022 Apr-Jun.

Affiliations

¹ Department of Ophthalmology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, United States.
² Eye Research Center, Eye Department, The Five Senses Health Institute, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Navid Manafi et al. J Ophthalmic Vis Res. 2022.

. 2022 Apr 29;17(2):309-310.

doi: 10.18502/jovr.v17i2.10825. eCollection 2022 Apr-Jun.

¹ Department of Ophthalmology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, United States.
² Eye Research Center, Eye Department, The Five Senses Health Institute, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

No abstract available

References

1. Aghdam KA, Sanjari MS, Manafi N, Khorramdel S. Temporal artery biopsy for diagnosing giant cell arteritis: A ten-year review. J Ophthalmic Vis Res. 2020;15:201–209. - PMC - PubMed
1. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33:1122–1128. - PubMed
1. Mahr A, Saba M, Kambouchner M, Polivka M, Baudrimont M, Brocheriou I, et al. - PMC - PubMed
1. Navahi RA, Chaibakhsh S, Alemzadeh SA. The adequate number of histopathology cross-sections of temporal artery biopsy in establishing the diagnosis of giant cell arteritis. J Ophthalmic Vis Res. 2021;16:77–83. - PMC - PubMed
1. Dinkin M, Johnson E. One giant step for giant cell arteritis: Updates in diagnosis and treatment. Curr Treat Options Neurol. 2021;23:6. - PMC - PubMed